tiprankstipranks
Blurbs

Analysts Offer Insights on Services Companies: Repay Holdings (RPAY), Benson Hill (BHIL) and AbSci (ABSI)

Companies in the Services sector have received a lot of coverage today as analysts weigh in on Repay Holdings (RPAYResearch Report), Benson Hill (BHILResearch Report) and AbSci (ABSIResearch Report).

Repay Holdings (RPAY)

Morgan Stanley analyst James Faucette maintained a Hold rating on Repay Holdings today and set a price target of $8.00. The company’s shares closed last Thursday at $6.85, close to its 52-week low of $4.37.

According to TipRanks.com, Faucette is a 5-star analyst with an average return of 8.4% and a 67.0% success rate. Faucette covers the Technology sector, focusing on stocks such as Clearwater Analytics Holdings, SS&C Technologies Holdings, and Automatic Data Processing.

Repay Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $10.57, which is an 80.7% upside from current levels. In a report released today, Credit Suisse also maintained a Hold rating on the stock with a $8.50 price target.

See the top stocks recommended by analysts >>

Benson Hill (BHIL)

In a report released today, Ben Klieve from Lake Street reiterated a Buy rating on Benson Hill, with a price target of $7.00. The company’s shares closed last Thursday at $3.17, close to its 52-week low of $2.33.

According to TipRanks.com, Klieve is ranked #442 out of 8037 analysts.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Benson Hill with a $5.50 average price target.

AbSci (ABSI)

In a report released today, Gaurav Goparaju from Berenberg Bank maintained a Buy rating on AbSci, with a price target of $28.00. The company’s shares closed last Thursday at $3.45, close to its 52-week low of $2.58.

According to TipRanks.com, Goparaju is ranked 0 out of 5 stars with an average return of -25.4% and a 24.4% success rate. Goparaju covers the Healthcare sector, focusing on stocks such as Recursion Pharmaceuticals, AbCellera Biologics, and Relay Therapeutics.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for AbSci with a $14.25 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on RPAY:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles